The expression of KLF15 was significantly downregulated in BC cells, such as BT-549 (expressing a high-level CCL2 mRNA; Fig. 1) and MDA-MB-231 cells, and BC tissues, and the methylation of the KLF15 gene promoter partially contributed to its downregulation. Here, CCL2 is linked to breast cancer.